Moreover, recent pancancer studies by The Cancer Genome Atlas Research in 9125 tumor samples have revealed that Hippo pathway components are widely altered in human cancers, such as downregulation of NF2, FAT1, TAOK1-3, WW45, and LATS1/2 [30, 31]. This evidence concerns the gene FAT1 and neoplasm.